Court restricts abortion access across the US by blocking the mailing of mifepristone
Briefly

Court restricts abortion access across the US by blocking the mailing of mifepristone
""Every abortion facilitated by FDA's action cancels Louisiana's ban on medical abortions and undermines its policy that 'every unborn child is human being from the moment of conception and is, therefore, a legal person.'""
""FDA officials under President Donald Trump have repeatedly stated the agency is conducting a new review of mifepristone's safety, at the direction of the president.""
A federal appeals court has restricted access to mifepristone, a common abortion method, by blocking its mailing. The 5th U.S. Circuit Court of Appeals mandates that the abortion pill be distributed only in-person at clinics. This decision follows the Supreme Court's 2022 ruling that allowed enforcement of abortion bans. The ruling states that every abortion facilitated by the FDA's action undermines Louisiana's abortion policy. The FDA is conducting a review of mifepristone's safety, but no completion date has been provided.
Read at www.npr.org
Unable to calculate read time
[
|
]